Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 6 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 19, 2017 Filed Sep 21, 2017 21:02 UTC |
Ajer Jeffrey RobertDirector
|
GrantCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-053626 · doc4.xml · nonDerivative · entry 2 Ajer Jeffrey Robert · CIK 0001557533 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 F1 · security: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock. F3 · deemedExecutionDate: This restricted stock unit award vests in full, one year following September 19, 2017. Read SEC document |
| September 19, 2017 Filed Sep 21, 2017 21:02 UTC |
Ajer Jeffrey RobertDirector
|
GrantCommon Stock | 13,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-053626 · doc4.xml · nonDerivative · entry 1 Ajer Jeffrey Robert · CIK 0001557533 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,500 F1 · security: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock. F2 · deemedExecutionDate: This restricted stock unit award vests over three years in equal annual installments beginning on September 19, 2017. Read SEC document |
| September 19, 2017 Filed Sep 21, 2017 20:57 UTC |
WINGER DENNIS LDirector
|
GrantStock Option · Derivative | 22,500 | $0.00 Strike: $21.75 | $0.00 |
DisclosureSEC source: 0001209191-17-053625 · doc4.xml · derivative · entry 3 WINGER DENNIS L · CIK 0001222645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: common stock · 22,500 shares Expires 2025-09-18 F3 · derivative.exercise_date: This stock option vests in equal monthly installments over the one-year period beginning on September 30, 2017. Read SEC document |
| September 19, 2017 Filed Sep 21, 2017 20:57 UTC |
WINGER DENNIS LDirector
|
GrantCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-053625 · doc4.xml · nonDerivative · entry 1 WINGER DENNIS L · CIK 0001222645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,250 F1 · security: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock. F2 · deemedExecutionDate: This restricted stock unit award vests in full, one year following September 19, 2017. Read SEC document |
| September 19, 2017 Filed Sep 21, 2017 20:56 UTC |
KUEBLER CHRISTOPHER ADirector
|
GrantStock Option · Derivative | 22,500 | $0.00 Strike: $21.75 | $0.00 |
DisclosureSEC source: 0001209191-17-053623 · doc4.xml · derivative · entry 2 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: common stock · 22,500 shares Expires 2025-09-18 F3 · derivative.exercise_date: This stock option vests in equal monthly installments over the one-year period beginning on September 30, 2017. Read SEC document |
| September 19, 2017 Filed Sep 21, 2017 20:56 UTC |
KUEBLER CHRISTOPHER ADirector
|
GrantCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-053623 · doc4.xml · nonDerivative · entry 1 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,500 F1 · security: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock. F2 · deemedExecutionDate: This restricted stock unit award vests in full, one year following September 19, 2017. Read SEC document |
| September 19, 2017 Filed Sep 21, 2017 20:51 UTC |
WHITFIELD ROY ADirector
|
GrantStock Option · Derivative | 22,500 | $0.00 Strike: $21.75 | $0.00 |
DisclosureSEC source: 0001209191-17-053618 · doc4.xml · derivative · entry 3 WHITFIELD ROY A · CIK 0000936728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: common stock · 22,500 shares Expires 2025-09-18 F3 · derivative.exercise_date: This stock option vests in equal monthly installments over the one-year period beginning on September 30, 2017. Read SEC document |
| September 19, 2017 Filed Sep 21, 2017 20:51 UTC |
WHITFIELD ROY ADirector
|
GrantCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-053618 · doc4.xml · nonDerivative · entry 1 WHITFIELD ROY A · CIK 0000936728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,000 F1 · security: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock. F2 · deemedExecutionDate: This restricted stock unit award vests in full, one year following September 19, 2017. Read SEC document |
| September 19, 2017 Filed Sep 21, 2017 20:49 UTC |
Lingnau LutzDirector
|
GrantStock Option · Derivative | 22,500 | $0.00 Strike: $21.75 | $0.00 |
DisclosureSEC source: 0001209191-17-053617 · doc4.xml · derivative · entry 2 Lingnau Lutz · CIK 0001354179 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: common stock · 22,500 shares Expires 2025-09-18 F3 · derivative.exercise_date: This stock option vests in equal monthly installments over the one-year period beginning on September 30, 2017. Read SEC document |
| September 19, 2017 Filed Sep 21, 2017 20:49 UTC |
Lingnau LutzDirector
|
GrantCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-053617 · doc4.xml · nonDerivative · entry 1 Lingnau Lutz · CIK 0001354179 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,450 F1 · security: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock. F2 · deemedExecutionDate: This restricted stock unit award vests in full, one year following September 19, 2017. Read SEC document |
| September 19, 2017 Filed Sep 21, 2017 20:46 UTC |
Krivulka Joseph JDirector
|
GrantStock Option · Derivative | 22,500 | $0.00 Strike: $21.75 | $0.00 |
DisclosureSEC source: 0001209191-17-053615 · doc4.xml · derivative · entry 2 Krivulka Joseph J · CIK 0001296750 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: common stock · 22,500 shares Expires 2025-09-18 F3 · derivative.exercise_date: This stock option vests in equal monthly installments over the one-year period beginning on September 30, 2017. Read SEC document |
| September 19, 2017 Filed Sep 21, 2017 20:46 UTC |
Krivulka Joseph JDirector
|
GrantCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-053615 · doc4.xml · nonDerivative · entry 1 Krivulka Joseph J · CIK 0001296750 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,000 F1 · security: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock. F2 · deemedExecutionDate: This restricted stock unit award vests in full, one year following September 19, 2017. Read SEC document |
| September 19, 2017 Filed Sep 21, 2017 20:43 UTC |
GREER R SCOTTDirector
|
GrantStock Option · Derivative | 22,500 | $0.00 Strike: $21.75 | $0.00 |
DisclosureSEC source: 0001209191-17-053613 · doc4.xml · derivative · entry 2 GREER R SCOTT · CIK 0001211703 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: common stock · 22,500 shares Expires 2025-09-18 F3 · derivative.exercise_date: This stock option vests in equal monthly installments over the one-year period beginning on September 30, 2017. Read SEC document |
| September 19, 2017 Filed Sep 21, 2017 20:43 UTC |
GREER R SCOTTDirector
|
GrantCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-053613 · doc4.xml · nonDerivative · entry 1 GREER R SCOTT · CIK 0001211703 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,333 F1 · security: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock. F2 · deemedExecutionDate: This restricted stock unit award vests in full, one year following September 19, 2017. Read SEC document |
| September 19, 2017 Filed Sep 21, 2017 20:40 UTC |
CHESS ROBERTDirector
|
GrantStock Option · Derivative | 22,500 | $0.00 Strike: $21.75 | $0.00 |
DisclosureSEC source: 0001209191-17-053611 · doc4.xml · derivative · entry 2 CHESS ROBERT · CIK 0001227886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: common stock · 22,500 shares Expires 2025-09-18 F3 · derivative.exercise_date: This stock option vests in equal monthly installments over the one-year period beginning on September 30, 2017. Read SEC document |
| September 19, 2017 Filed Sep 21, 2017 20:40 UTC |
CHESS ROBERTDirector
|
GrantCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-053611 · doc4.xml · nonDerivative · entry 1 CHESS ROBERT · CIK 0001227886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,623 F1 · security: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock. F2 · deemedExecutionDate: This restricted stock unit award vests in full, one year following September 19, 2017. Read SEC document |
| September 06, 2017 Filed Sep 8, 2017 22:08 UTC |
ROBIN HOWARD WDirector · President & CEO
|
Exercise / conversionStock Option · Derivative | 83,333 | $0.00 Strike: $11.34 | $0.00 |
DisclosureSEC source: 0001209191-17-052127 · doc4.xml · derivative · entry 4 ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,333 Underlying: Common Stock · 83,333 shares Expires 2018-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin on March 9, 2017 related to 500,000 stock options scheduled to expire on January 31, 2018. Read SEC document |
| September 06, 2017 Filed Sep 8, 2017 22:08 UTC |
ROBIN HOWARD WDirector · President & CEO
|
SaleCommon Stock | 83,333 | $21.54 | $1,794,992.82 |
DisclosureSEC source: 0001209191-17-052127 · doc4.xml · nonDerivative · entry 2 ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,504 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin on March 9, 2017 related to 500,000 stock options scheduled to expire on January 31, 2018. F2 · price: This transaction was executed in multiple trades at prices ranging from $21.09 to $21.79. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| September 06, 2017 Filed Sep 8, 2017 22:08 UTC |
ROBIN HOWARD WDirector · President & CEO
|
Exercise / conversionCommon Stock | 83,333 | $11.34 | $944,996.22 |
DisclosureSEC source: 0001209191-17-052127 · doc4.xml · nonDerivative · entry 1 ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,837 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin on March 9, 2017 related to 500,000 stock options scheduled to expire on January 31, 2018. Read SEC document |
| August 16, 2017 Filed Aug 18, 2017 23:05 UTC |
Thomsen Jillian B.SVP & Chief Accounting Officer
|
SaleCommon Stock | 2,648 | $19.32 | $51,159.36 |
DisclosureSEC source: 0001209191-17-049669 · doc4.xml · nonDerivative · entry 1 Thomsen Jillian B. · CIK 0001433457 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,838 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: This transaction was executed in multiple trades at prices ranging from $19.02 to $19.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. F3 · balance_after: This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 3,250 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c). Read SEC document |
| August 16, 2017 Filed Aug 18, 2017 23:05 UTC |
ROBIN HOWARD WDirector · President & CEO
|
Exercise / conversionStock Option · Derivative | 83,334 | $0.00 Strike: $11.34 | $0.00 |
DisclosureSEC source: 0001209191-17-049668 · doc4.xml · derivative · entry 5 ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 416,666 Underlying: Common Stock · 83,334 shares Expires 2018-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin on March 9, 2017 related to 500,000 stock options scheduled to expire on January 31, 2018. Read SEC document |
| August 16, 2017 Filed Aug 18, 2017 23:05 UTC |
ROBIN HOWARD WDirector · President & CEO
|
SaleCommon Stock | 83,334 | $19.25 | $1,604,179.50 |
DisclosureSEC source: 0001209191-17-049668 · doc4.xml · nonDerivative · entry 3 ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,504 F3 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin on March 9, 2017 related to 500,000 stock options scheduled to expire on January 31, 2018. F4 · price: This transaction was executed in multiple trades at prices ranging from $19.02 to $19.60. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| August 16, 2017 Filed Aug 18, 2017 23:05 UTC |
ROBIN HOWARD WDirector · President & CEO
|
Exercise / conversionCommon Stock | 83,334 | $11.34 | $945,007.56 |
DisclosureSEC source: 0001209191-17-049668 · doc4.xml · nonDerivative · entry 2 ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Robin on March 9, 2017 related to 500,000 stock options scheduled to expire on January 31, 2018. Read SEC document |
| August 16, 2017 Filed Aug 18, 2017 23:05 UTC |
ROBIN HOWARD WDirector · President & CEO
|
SaleCommon Stock | 8,380 | $19.32 | $161,901.60 |
DisclosureSEC source: 0001209191-17-049668 · doc4.xml · nonDerivative · entry 1 ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,504 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: This transaction was executed in multiple trades at prices ranging from $19.02 to $19.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| August 16, 2017 Filed Aug 18, 2017 23:04 UTC |
Nicholson JohnSVP & Chief Operating Officer
|
SaleCommon Stock | 3,177 | $19.32 | $61,379.64 |
DisclosureSEC source: 0001209191-17-049667 · doc4.xml · nonDerivative · entry 1 Nicholson John · CIK 0001420766 · SVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,066 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: This transaction was executed in multiple trades at prices ranging from $19.02 to $19.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| August 16, 2017 Filed Aug 18, 2017 23:04 UTC |
Labrucherie Gil MSVP & Chief Financial Officer
|
SaleCommon Stock | 3,177 | $19.32 | $61,379.64 |
DisclosureSEC source: 0001209191-17-049666 · doc4.xml · nonDerivative · entry 1 Labrucherie Gil M · CIK 0001394875 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,414 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: This transaction was executed in multiple trades at prices ranging from $19.02 to $19.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. F3 · balance_after: This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 3,250 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c). Read SEC document |
| August 16, 2017 Filed Aug 18, 2017 23:03 UTC |
Hora ManinderSVP Pharma Dev & Mfg Ops
|
SaleCommon Stock | 2,956 | $19.32 | $57,109.92 |
DisclosureSEC source: 0001209191-17-049665 · doc4.xml · nonDerivative · entry 1 Hora Maninder · CIK 0001443159 · SVP Pharma Dev & Mfg Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,233 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: This transaction was executed in multiple trades at prices ranging from $19.02 to $19.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. F3 · balance_after: This number includes 6,000 shares held by the reporting person from the Issuer's ESPP plan. The acquisition of these shares under this plan is exempt under Rule 16b-3(c). Read SEC document |
| August 16, 2017 Filed Aug 18, 2017 23:02 UTC |
Gergel Ivan P.SVP & Chief Medical Officer
|
SaleCommon Stock | 1,997 | $19.32 | $38,582.04 |
DisclosureSEC source: 0001209191-17-049664 · doc4.xml · nonDerivative · entry 1 Gergel Ivan P. · CIK 0001328288 · SVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,575 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: This transaction was executed in multiple trades at prices ranging from $19.02 to $19.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| August 16, 2017 Filed Aug 18, 2017 23:01 UTC |
Doberstein Stephen KSVP & Chief Scientific Officer
|
SaleCommon Stock | 1,701 | $19.32 | $32,863.32 |
DisclosureSEC source: 0001209191-17-049663 · doc4.xml · nonDerivative · entry 1 Doberstein Stephen K · CIK 0001480111 · SVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,102 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: This transaction was executed in multiple trades at prices ranging from $19.02 to $19.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| August 10, 2017 Filed Aug 14, 2017 13:07 UTC |
WHITFIELD ROY ADirector
|
PurchaseCommon Stock | 35,000 | $17.95 | $628,250.00 |
DisclosureSEC source: 0001209191-17-048678 · doc4.xml · nonDerivative · entry 1 WHITFIELD ROY A · CIK 0000936728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,000 F1 · price: This transaction was executed in multiple trades at prices ranging from $17.89 to $17.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| July 18, 2017 Filed Jul 20, 2017 21:08 UTC |
Gergel Ivan P.SVP & Chief Medical Officer
|
Exercise / conversionStock Option · Derivative | 54,920 | $0.00 Strike: $11.04 | $0.00 |
DisclosureSEC source: 0001209191-17-045842 · doc4.xml · derivative · entry 3 Gergel Ivan P. · CIK 0001328288 · SVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 413,752 Underlying: Common Stock · 54,920 shares Expires 2022-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| July 18, 2017 Filed Jul 20, 2017 21:08 UTC |
Gergel Ivan P.SVP & Chief Medical Officer
|
SaleCommon Stock | 54,920 | $21.10 | $1,158,812.00 |
DisclosureSEC source: 0001209191-17-045842 · doc4.xml · nonDerivative · entry 2 Gergel Ivan P. · CIK 0001328288 · SVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,572 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: This transaction was executed in multiple trades at prices ranging from $21.04 to $21.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| July 18, 2017 Filed Jul 20, 2017 21:08 UTC |
Gergel Ivan P.SVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 54,920 | $11.04 | $606,316.80 |
DisclosureSEC source: 0001209191-17-045842 · doc4.xml · nonDerivative · entry 1 Gergel Ivan P. · CIK 0001328288 · SVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,492 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| July 14, 2017 Filed Jul 19, 2017 00:02 UTC |
Lingnau LutzDirector
|
Exercise / conversionStock Option · Derivative | 30,000 | $0.00 Strike: $14.26 | $0.00 |
DisclosureSEC source: 0001209191-17-045609 · doc4.xml · derivative · entry 3 Lingnau Lutz · CIK 0001354179 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2018-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| July 14, 2017 Filed Jul 19, 2017 00:02 UTC |
Lingnau LutzDirector
|
SaleCommon Stock | 30,000 | $20.76 | $622,800.00 |
DisclosureSEC source: 0001209191-17-045609 · doc4.xml · nonDerivative · entry 2 Lingnau Lutz · CIK 0001354179 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,450 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.40 to $20.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| July 14, 2017 Filed Jul 19, 2017 00:02 UTC |
Lingnau LutzDirector
|
Exercise / conversionCommon Stock | 30,000 | $14.26 | $427,800.00 |
DisclosureSEC source: 0001209191-17-045609 · doc4.xml · nonDerivative · entry 1 Lingnau Lutz · CIK 0001354179 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| July 12, 2017 Filed Jul 14, 2017 00:01 UTC |
Gergel Ivan P.SVP & Chief Medical Officer
|
Exercise / conversionStock Option · Derivative | 36,691 | $0.00 Strike: $11.04 | $0.00 |
DisclosureSEC source: 0001209191-17-045121 · doc4.xml · derivative · entry 6 Gergel Ivan P. · CIK 0001328288 · SVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 468,672 Underlying: Common Stock · 36,691 shares Expires 2022-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| July 12, 2017 Filed Jul 14, 2017 00:01 UTC |
Gergel Ivan P.SVP & Chief Medical Officer
|
SaleCommon Stock | 36,691 | $21.09 | $773,813.19 |
DisclosureSEC source: 0001209191-17-045121 · doc4.xml · nonDerivative · entry 4 Gergel Ivan P. · CIK 0001328288 · SVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,572 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: This transaction was executed in multiple trades at prices ranging from $21.04 to $21.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| July 12, 2017 Filed Jul 14, 2017 00:01 UTC |
Gergel Ivan P.SVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 36,691 | $11.04 | $405,068.64 |
DisclosureSEC source: 0001209191-17-045121 · doc4.xml · nonDerivative · entry 3 Gergel Ivan P. · CIK 0001328288 · SVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,263 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| July 11, 2017 Filed Jul 14, 2017 00:01 UTC |
Gergel Ivan P.SVP & Chief Medical Officer
|
Exercise / conversionStock Option · Derivative | 8,389 | $0.00 Strike: $11.04 | $0.00 |
DisclosureSEC source: 0001209191-17-045121 · doc4.xml · derivative · entry 5 Gergel Ivan P. · CIK 0001328288 · SVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 505,363 Underlying: Common Stock · 8,389 shares Expires 2022-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| July 11, 2017 Filed Jul 14, 2017 00:01 UTC |
Gergel Ivan P.SVP & Chief Medical Officer
|
SaleCommon Stock | 8,389 | $21.04 | $176,504.56 |
DisclosureSEC source: 0001209191-17-045121 · doc4.xml · nonDerivative · entry 2 Gergel Ivan P. · CIK 0001328288 · SVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,572 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: This transaction was executed in multiple trades at prices ranging from $21.04 to $21.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| July 11, 2017 Filed Jul 14, 2017 00:01 UTC |
Gergel Ivan P.SVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 8,389 | $11.04 | $92,614.56 |
DisclosureSEC source: 0001209191-17-045121 · doc4.xml · nonDerivative · entry 1 Gergel Ivan P. · CIK 0001328288 · SVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,961 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| June 26, 2017 Filed Jun 28, 2017 22:05 UTC |
Krivulka Joseph JDirector
|
Exercise / conversionStock Option · Derivative | 15,000 | $0.00 Strike: $8.37 | $0.00 |
DisclosureSEC source: 0001209191-17-042168 · doc4.xml · derivative · entry 2 Krivulka Joseph J · CIK 0001296750 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2017-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 26, 2017 Filed Jun 28, 2017 22:05 UTC |
Krivulka Joseph JDirector
|
Exercise / conversionCommon Stock | 15,000 | $8.37 | $125,550.00 |
DisclosureSEC source: 0001209191-17-042168 · doc4.xml · nonDerivative · entry 1 Krivulka Joseph J · CIK 0001296750 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2017 Filed Jun 9, 2017 22:02 UTC |
Nicholson JohnSVP & Chief Operating Officer
|
Exercise / conversionStock Option · Derivative | 150,000 | $0.00 Strike: $6.34 | $0.00 |
DisclosureSEC source: 0001209191-17-038973 · doc4.xml · derivative · entry 3 Nicholson John · CIK 0001420766 · SVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 150,000 shares Expires 2017-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and is related to a stock option that was scheduled to expire on June 9, 2017. Read SEC document |
| June 07, 2017 Filed Jun 9, 2017 22:02 UTC |
Nicholson JohnSVP & Chief Operating Officer
|
SaleCommon Stock | 101,700 | $19.24 | $1,956,708.00 |
DisclosureSEC source: 0001209191-17-038973 · doc4.xml · nonDerivative · entry 2 Nicholson John · CIK 0001420766 · SVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,243 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and is related to a stock option that was scheduled to expire on June 9, 2017. F2 · price: This transaction was executed in multiple trades at prices ranging from $18.83 to $19.74. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| June 07, 2017 Filed Jun 9, 2017 22:02 UTC |
Nicholson JohnSVP & Chief Operating Officer
|
Exercise / conversionCommon Stock | 150,000 | $6.34 | $951,000.00 |
DisclosureSEC source: 0001209191-17-038973 · doc4.xml · nonDerivative · entry 1 Nicholson John · CIK 0001420766 · SVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 328,943 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and is related to a stock option that was scheduled to expire on June 9, 2017. Read SEC document |
| May 16, 2017 Filed May 19, 2017 00:50 UTC |
Thomsen Jillian B.SVP & Chief Accounting Officer
|
SaleCommon Stock | 2,651 | $19.55 | $51,827.05 |
DisclosureSEC source: 0001209191-17-033772 · doc4.xml · nonDerivative · entry 1 Thomsen Jillian B. · CIK 0001433457 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,986 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: This transaction was executed in multiple trades at prices ranging from $19.31 to $19.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. F3 · balance_after: This number includes 988 shares held by the reporting person in the Issuer's 401(K) plan and 2,750 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c). Read SEC document |
| May 16, 2017 Filed May 19, 2017 00:50 UTC |
ROBIN HOWARD WDirector · President & CEO
|
SaleCommon Stock | 8,388 | $19.55 | $163,985.40 |
DisclosureSEC source: 0001209191-17-033771 · doc4.xml · nonDerivative · entry 1 ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,884 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: This transaction was executed in multiple trades at prices ranging from $19.31 to $19.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| May 16, 2017 Filed May 19, 2017 00:49 UTC |
Nicholson JohnSVP & Chief Operating Officer
|
SaleCommon Stock | 3,146 | $19.55 | $61,504.30 |
DisclosureSEC source: 0001209191-17-033770 · doc4.xml · nonDerivative · entry 1 Nicholson John · CIK 0001420766 · SVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,943 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: This transaction was executed in multiple trades at prices ranging from $19.31 to $19.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.